• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017

tetano

Editor, Senior Moderator
BMC Infect Dis. 2019 Nov 21;19(1):990. doi: 10.1186/s12879-019-4621-z. [h=1]Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017.[/h]
Puzelli S[SUP]1[/SUP], Di Martino A[SUP]2[/SUP], Facchini M[SUP]2[/SUP], Fabiani C[SUP]2[/SUP], Calzoletti L[SUP]2[/SUP], Di Mario G[SUP]2[/SUP], Palmieri A[SUP]2[/SUP], Affanni P[SUP]3[/SUP], Camilloni B[SUP]4[/SUP], Chironna M[SUP]5[/SUP], D'Agaro P[SUP]6[/SUP], Giannecchini S[SUP]7[/SUP], Pariani E[SUP]8[/SUP], Serra C[SUP]9[/SUP], Rizzo C[SUP]2[/SUP], Bella A[SUP]2[/SUP], Donatelli I[SUP]2[/SUP], Castrucci MR[SUP]2[/SUP]; Italian Influenza Laboratory Network.
[h=3]Collaborators (17)[/h]

[h=3]Author information[/h] 1 Department of Infectious Diseases, Istituto Superiore di Sanit? (ISS), Viale Regina Elena 299, Rome, Italy. simona.puzelli@iss.it. 2 Department of Infectious Diseases, Istituto Superiore di Sanit? (ISS), Viale Regina Elena 299, Rome, Italy. 3 University of Parma, Parma, Italy. 4 University of Perugia, Perugia, Italy. 5 Department of Biomedical Science and Human Oncology, University of Bari, Bari, Italy. 6 University of Trieste, Trieste, Italy. 7 University of Florence, Florence, Italy. 8 Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. 9 University of Sassari, Sassari, Italy.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Since 1985, two antigenically distinct lineages of influenza B viruses (Victoria-like and Yamagata-like) have circulated globally. Trivalent seasonal influenza vaccines contain two circulating influenza A strains but a single B strain and thus provide limited immunity against circulating B strains of the lineage not included in the vaccine. In this study, we describe the characteristics of influenza B viruses that caused respiratory illness in the population in Italy over 13 consecutive seasons of virological surveillance, and the match between the predominant influenza B lineage and the vaccine B lineage, in each season.
[h=4]METHODS:[/h] From 2004 to 2017, 26,886 laboratory-confirmed influenza cases were registered in Italy, of which 18.7% were type B. Among them, the lineage of 2465 strains (49%) was retrieved or characterized in this study by a real-time RT-PCR assay and/or sequencing of the hemagglutinin (HA) gene.
[h=4]RESULTS:[/h] Co-circulation of both B lineages was observed each season, although in different proportions every year. Overall, viruses of B/Victoria and B/Yamagata lineages caused 53.3 and 46.7% of influenza B infections, respectively. A higher proportion of infections with both lineages was detected in children, and there was a declining frequency of B/Victoria detections with age. A mismatch between the vaccine and the predominant influenza B lineage occurred in eight out of thirteen influenza seasons under study. Considering the seasons when B accounted for > 20% of all laboratory-confirmed influenza cases, a mismatch was observed in four out of six seasons. Phylogenetic analysis of the HA1 domain confirmed the co-circulation of both lineages and revealed a mixed circulation of distinct evolutionary viral variants, with different levels of match to the vaccine strains.
[h=4]CONCLUSIONS:[/h] This study contributes to the understanding of the circulation of influenza B viruses in Italy. We found a continuous co-circulation of both B lineages in the period 2004-2017, and determined that children were particularly vulnerable to Victoria-lineage influenza B virus infections. An influenza B lineage mismatch with the trivalent vaccine occurred in about two-thirds of cases.


[h=4]KEYWORDS:[/h] Influenza B virus; Influenza virological surveillance; Italy; Vaccine match; Victoria lineage; Yamagata lineage

PMID: 31752738 DOI: 10.1186/s12879-019-4621-z
Free full text
 
Back
Top Bottom